Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

CMC Application Task Force

CMC Application Task Force

BACK

CMC Application Task Force

Mission: Promote use of in silico solutions in CMC throughout product lifecycle

In the realm of pharmaceuticals, the pursuit of efficiency, safety, and efficacy is unending.

In silico solutions offer a promising avenue to transform traditional CMC processes.

By leveraging advanced computational tools, we can streamline development, enhance quality, and expedite regulatory approvals.

In silico technology not only accelerates development but also minimizes costs and reduces time on traditional clinical trials.

However, widespread adoption of in silico solutions in CMC requires concerted efforts from stakeholders across the pharmaceutical industry and collaboration between academia, industry, and regulatory agencies is vital to establish standards, validate models, and ensure acceptance of computational approaches in regulatory submissions.

With the mission of promoting the use of in silico technology in CMC throughout product lifecycle, the CMC Application TF’s main goals include:

Goals

  • Create an expert group among our members
  • Compile and review existing in silico solutions supporting CMC: to support tech transfer during clinical development and beyond
  • Promote use of in silico approaches in formulation development
  • Provide PRELIMINARY guidance on generating in silico data supporting batch size and CQAs strategy discussion with Regulatory Agencies


Ani Amar

Ani Amar

Co-chair of CMC Application TF

Postdoctoral fellow, Computational modeling of the heart at ELEM Biotech

READ BIO
Himanshu Kaul

Himanshu Kaul

Co-chair of CMC Application TF

Royal Academy of Engineering Research Fellow University of Leicester

READ BIO

NEWS

News Avicenna Day (AAD) 2024 Recordings Now Available

Avicenna Day (AAD) 2024 Recordings Now Available

Did you enjoy AAD 2024 and want to rewatch presentations from world-class thought leaders? Or did you miss the event? This news is for you!

News BioTechX event, Basel

BioTechX event, Basel

The BioTechX event in Basel provided an excellent opportunity for the Avicenna Alliance to engage with key pharmaceutical players and discuss the growing role of in silico methods in drug discovery and development, drug delivery and manufacturing.

News Nobel Prize for in silico modelling

Nobel Prize for in silico modelling

Congratulations to the winners of the 2024 Nobel Prize in Chemistry! This year's prestigious award honours revolutionary advancements in computational modelling, specifically in the study and design of proteins—the fundamental components of life.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2024 Avicenna Alliance | powered by We Berry